120 related articles for article (PubMed ID: 22806713)
21. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
[TBL] [Abstract][Full Text] [Related]
22. [Oral sildenafil for pulmonary hypertension in neonates].
Gutiérrez Nicolás F; Viña Romero MM; González Carretero P; Merino Alonso J
Farm Hosp; 2011; 35(3):157-8. PubMed ID: 21439880
[No Abstract] [Full Text] [Related]
23. Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle.
Borgdorff MA; Bartelds B; Dickinson MG; Boersma B; Weij M; Zandvoort A; Silljé HH; Steendijk P; de Vroomen M; Berger RM
Eur J Heart Fail; 2012 Sep; 14(9):1067-74. PubMed ID: 22730335
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis.
Moinzadeh P; Hunzelmann N; Krieg T
J Am Acad Dermatol; 2011 Sep; 65(3):e102-e104. PubMed ID: 21839301
[No Abstract] [Full Text] [Related]
25. [The prescription].
Rabe J
MMW Fortschr Med; 2013 Jan; 155(1):28. PubMed ID: 23573716
[No Abstract] [Full Text] [Related]
26. Right ventricular function with hypoxic exercise: effects of sildenafil.
Kjaergaard J; Snyder EM; Hassager C; Olson TP; Oh JK; Johnson BD; Frantz RP
Eur J Appl Physiol; 2007 Dec; 102(1):87-95. PubMed ID: 17909844
[TBL] [Abstract][Full Text] [Related]
27. "Out of the blue"-safety and efficacy of pulmonary hypertension treatment in childhood*.
Kraemer U; Wildschuth E; Tibboel D
Pediatr Crit Care Med; 2014 May; 15(4):377-8. PubMed ID: 24801422
[No Abstract] [Full Text] [Related]
28. Effect of oral sildenafil on skin postocclusive reactive hyperemia in healthy volunteers.
Blaise S; Roustit M; Millet C; Cracowski JL
Microcirculation; 2011 Aug; 18(6):448-51. PubMed ID: 21443694
[TBL] [Abstract][Full Text] [Related]
29. Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging.
Giannetta E; Isidori AM; Galea N; Carbone I; Mandosi E; Vizza CD; Naro F; Morano S; Fedele F; Lenzi A
Circulation; 2012 May; 125(19):2323-33. PubMed ID: 22496161
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.
Guazzi M; Vicenzi M; Arena R; Guazzi MD
Circulation; 2011 Jul; 124(2):164-74. PubMed ID: 21709061
[TBL] [Abstract][Full Text] [Related]
31. Effect of a single oral dose of sildenafil on right-to-left shunt.
Sallustio F; Di Legge S; Diomedi M; Stanzione P
Cerebrovasc Dis; 2011; 32(3):296-7. PubMed ID: 21912110
[No Abstract] [Full Text] [Related]
32. Sildenafil weaning after discharge in infants with congenital diaphragmatic hernia.
Behrsin J; Cheung M; Patel N
Pediatr Cardiol; 2013; 34(8):1844-7. PubMed ID: 23877431
[TBL] [Abstract][Full Text] [Related]
33. The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.
Jasińska-Stroschein M; Owczarek J; Łuczak A; Orszulak-Michalak D
Pharmacology; 2013; 91(3-4):178-84. PubMed ID: 23428587
[TBL] [Abstract][Full Text] [Related]
34. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
[TBL] [Abstract][Full Text] [Related]
35. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
[TBL] [Abstract][Full Text] [Related]
36. Sildenafil for the treatment of pulmonary hypertension in pediatric patients.
Huddleston AJ; Knoderer CA; Morris JL; Ebenroth ES
Pediatr Cardiol; 2009 Oct; 30(7):871-82. PubMed ID: 19705181
[TBL] [Abstract][Full Text] [Related]
37. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
38. Oral sildenafil to control pulmonary hypertension after congenital heart surgery.
Peiravian F; Amirghofran AA; Borzouee M; Ajami GH; Sabri MR; Kolaee S
Asian Cardiovasc Thorac Ann; 2007 Apr; 15(2):113-7. PubMed ID: 17387192
[TBL] [Abstract][Full Text] [Related]
39. Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension.
Yanagisawa R; Kataoka M; Taguchi H; Kawakami T; Tamura Y; Fukuda K; Yoshino H; Satoh T
Circ J; 2012; 76(5):1245-52. PubMed ID: 22333215
[TBL] [Abstract][Full Text] [Related]
40. Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.
Vachiery JL; Huez S; Gillies H; Layton G; Hayashi N; Gao X; Naeije R
Br J Clin Pharmacol; 2011 Feb; 71(2):289-92. PubMed ID: 21219411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
